Dubai - Sharikat Mubasher: Metabolic, a Dubai-based hybrid digital therapeutics company, successfully closed a strategic growth capital facility in partnership with RAKBANK to fuel expansions into the largest global healthcare markets, including the UK and the US.

In a recent statement, Metabolic revealed that the new facility will enable it to accelerate its physical and digital footprint across three continents, combining in-person clinical excellence with real-time data and a multi-disciplinary "human-in-the-loop" approach.

Securing the growth capital facility from RAKBANK signals a significant maturation of Metabolic’s business, underscores the bankability of its model, and provides the capital necessary to fuel an aggressive international roadmap.

Ali Hashemi, Co-Founder and CEO of Metabolic, said: “We have spent the last several years proving that our model doesn't just work; it outperforms. Having been the only provider in the region to have our real-world outcomes validated and published by the New England Journal of Medicine Group, we are now taking that 'Dubai-proven' blueprint to the global stage. We are solving a universal problem with a uniquely sophisticated solution.”

In turn, Emad Ahmed, EVP and Head of Commercial Banking at RAKBANK, commented: “We are pleased to support Metabolic as it scales access to high-impact healthcare services. We believe outcomes-driven, technology-enabled care models will play an increasingly important role in the future of prevention and chronic disease management in the UAE.”

Metabolic integrates continuous data monitoring with multi-disciplinary clinical teams, replacing traditional episodic care with a continuous "human-in-the-loop" model.